Pentose phosphate pathway in disease and therapy

Mahbuba Rahman, Mohammad Rubayet Hasan

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Pentose phosphate (PP) pathway, which is ubiquitously present in all living organisms, is one of the major metabolic pathways associated with glucose metabolism. The most important functions of this pathway includes the generation of reducing equivalents in the form of NADPH for reductive biosynthesis, and production of ribose sugars for the biosynthesis of nucleotides, amino acids, and other macromolecules required by all living cells. Under normal conditions of growth, PP pathway is important for cell cycle progression, myelin formation, and the maintenance of the structure and function of brain, liver, cortex and other organs. Under diseased conditions, such as in cases of many metabolic, neurological or malignant diseases, pathological mechanisms augment due to defects in the PP pathway genes. Adoption of alternative metabolic pathways by cells that are metabolically abnormal, or malignant cells that are resistant to chemotherapeutic drugs often plays important roles in disease progression and severity. Accordingly, the PP pathway has been suggested to play critical roles in protecting cancer or abnormal cells by providing reduced environment, to protect cells from oxidative damage and generating structural components for nucleic acids biosynthesis. Novel drugs that targets one or more components of the PP pathway could potentially serve to overcome challenges associated with currently available therapeutic options for many metabolic and non-metabolic diseases. However, careful designing of drugs is critical that takes into the accounts of cell's broader genomic, proteomic and metabolic contexts under consideration, in order to avoid undesirable side-effects. In this review, we discuss the role of PP pathway under normal and abnormal physiological conditions and the potential of the PP pathway as a target for new drug development to treat metabolic and non-metabolic diseases.

Original languageEnglish
Pages (from-to)1-27
Number of pages27
JournalAdvanced Materials Research
Volume995
DOIs
Publication statusPublished - 2014
Externally publishedYes

Fingerprint

Phosphates
Biosynthesis
Cells
Nucleic acids
Nucleotides
Macromolecules
Metabolism
Sugars
Liver
Glucose
Amino acids
Brain
Genes
Defects
Metabolic Networks and Pathways

Keywords

  • Alzheimer's disease
  • Cancer
  • Chemoresistance
  • Chemotherapy
  • Epilepsy
  • Gene therapy
  • Glucose-6-phosphate dehydrogenase
  • Glutathione
  • Metabolic diseases
  • Metabolic flux analysis
  • Metabolomics
  • Nadph
  • Non-metabolic diseases
  • Novel drug discovery and development
  • Nucleotide biosynthesis
  • Pentose phosphate pathway
  • Transketolase

ASJC Scopus subject areas

  • Engineering(all)

Cite this

Pentose phosphate pathway in disease and therapy. / Rahman, Mahbuba; Hasan, Mohammad Rubayet.

In: Advanced Materials Research, Vol. 995, 2014, p. 1-27.

Research output: Contribution to journalArticle

Rahman, Mahbuba ; Hasan, Mohammad Rubayet. / Pentose phosphate pathway in disease and therapy. In: Advanced Materials Research. 2014 ; Vol. 995. pp. 1-27.
@article{e09f507cb54d4a02be2822689f856ab2,
title = "Pentose phosphate pathway in disease and therapy",
abstract = "Pentose phosphate (PP) pathway, which is ubiquitously present in all living organisms, is one of the major metabolic pathways associated with glucose metabolism. The most important functions of this pathway includes the generation of reducing equivalents in the form of NADPH for reductive biosynthesis, and production of ribose sugars for the biosynthesis of nucleotides, amino acids, and other macromolecules required by all living cells. Under normal conditions of growth, PP pathway is important for cell cycle progression, myelin formation, and the maintenance of the structure and function of brain, liver, cortex and other organs. Under diseased conditions, such as in cases of many metabolic, neurological or malignant diseases, pathological mechanisms augment due to defects in the PP pathway genes. Adoption of alternative metabolic pathways by cells that are metabolically abnormal, or malignant cells that are resistant to chemotherapeutic drugs often plays important roles in disease progression and severity. Accordingly, the PP pathway has been suggested to play critical roles in protecting cancer or abnormal cells by providing reduced environment, to protect cells from oxidative damage and generating structural components for nucleic acids biosynthesis. Novel drugs that targets one or more components of the PP pathway could potentially serve to overcome challenges associated with currently available therapeutic options for many metabolic and non-metabolic diseases. However, careful designing of drugs is critical that takes into the accounts of cell's broader genomic, proteomic and metabolic contexts under consideration, in order to avoid undesirable side-effects. In this review, we discuss the role of PP pathway under normal and abnormal physiological conditions and the potential of the PP pathway as a target for new drug development to treat metabolic and non-metabolic diseases.",
keywords = "Alzheimer's disease, Cancer, Chemoresistance, Chemotherapy, Epilepsy, Gene therapy, Glucose-6-phosphate dehydrogenase, Glutathione, Metabolic diseases, Metabolic flux analysis, Metabolomics, Nadph, Non-metabolic diseases, Novel drug discovery and development, Nucleotide biosynthesis, Pentose phosphate pathway, Transketolase",
author = "Mahbuba Rahman and Hasan, {Mohammad Rubayet}",
year = "2014",
doi = "10.4028/www.scientific.net/AMR.995.1",
language = "English",
volume = "995",
pages = "1--27",
journal = "Advanced Materials Research",
issn = "1022-6680",
publisher = "Trans Tech Publications",

}

TY - JOUR

T1 - Pentose phosphate pathway in disease and therapy

AU - Rahman, Mahbuba

AU - Hasan, Mohammad Rubayet

PY - 2014

Y1 - 2014

N2 - Pentose phosphate (PP) pathway, which is ubiquitously present in all living organisms, is one of the major metabolic pathways associated with glucose metabolism. The most important functions of this pathway includes the generation of reducing equivalents in the form of NADPH for reductive biosynthesis, and production of ribose sugars for the biosynthesis of nucleotides, amino acids, and other macromolecules required by all living cells. Under normal conditions of growth, PP pathway is important for cell cycle progression, myelin formation, and the maintenance of the structure and function of brain, liver, cortex and other organs. Under diseased conditions, such as in cases of many metabolic, neurological or malignant diseases, pathological mechanisms augment due to defects in the PP pathway genes. Adoption of alternative metabolic pathways by cells that are metabolically abnormal, or malignant cells that are resistant to chemotherapeutic drugs often plays important roles in disease progression and severity. Accordingly, the PP pathway has been suggested to play critical roles in protecting cancer or abnormal cells by providing reduced environment, to protect cells from oxidative damage and generating structural components for nucleic acids biosynthesis. Novel drugs that targets one or more components of the PP pathway could potentially serve to overcome challenges associated with currently available therapeutic options for many metabolic and non-metabolic diseases. However, careful designing of drugs is critical that takes into the accounts of cell's broader genomic, proteomic and metabolic contexts under consideration, in order to avoid undesirable side-effects. In this review, we discuss the role of PP pathway under normal and abnormal physiological conditions and the potential of the PP pathway as a target for new drug development to treat metabolic and non-metabolic diseases.

AB - Pentose phosphate (PP) pathway, which is ubiquitously present in all living organisms, is one of the major metabolic pathways associated with glucose metabolism. The most important functions of this pathway includes the generation of reducing equivalents in the form of NADPH for reductive biosynthesis, and production of ribose sugars for the biosynthesis of nucleotides, amino acids, and other macromolecules required by all living cells. Under normal conditions of growth, PP pathway is important for cell cycle progression, myelin formation, and the maintenance of the structure and function of brain, liver, cortex and other organs. Under diseased conditions, such as in cases of many metabolic, neurological or malignant diseases, pathological mechanisms augment due to defects in the PP pathway genes. Adoption of alternative metabolic pathways by cells that are metabolically abnormal, or malignant cells that are resistant to chemotherapeutic drugs often plays important roles in disease progression and severity. Accordingly, the PP pathway has been suggested to play critical roles in protecting cancer or abnormal cells by providing reduced environment, to protect cells from oxidative damage and generating structural components for nucleic acids biosynthesis. Novel drugs that targets one or more components of the PP pathway could potentially serve to overcome challenges associated with currently available therapeutic options for many metabolic and non-metabolic diseases. However, careful designing of drugs is critical that takes into the accounts of cell's broader genomic, proteomic and metabolic contexts under consideration, in order to avoid undesirable side-effects. In this review, we discuss the role of PP pathway under normal and abnormal physiological conditions and the potential of the PP pathway as a target for new drug development to treat metabolic and non-metabolic diseases.

KW - Alzheimer's disease

KW - Cancer

KW - Chemoresistance

KW - Chemotherapy

KW - Epilepsy

KW - Gene therapy

KW - Glucose-6-phosphate dehydrogenase

KW - Glutathione

KW - Metabolic diseases

KW - Metabolic flux analysis

KW - Metabolomics

KW - Nadph

KW - Non-metabolic diseases

KW - Novel drug discovery and development

KW - Nucleotide biosynthesis

KW - Pentose phosphate pathway

KW - Transketolase

UR - http://www.scopus.com/inward/record.url?scp=84905723168&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905723168&partnerID=8YFLogxK

U2 - 10.4028/www.scientific.net/AMR.995.1

DO - 10.4028/www.scientific.net/AMR.995.1

M3 - Article

VL - 995

SP - 1

EP - 27

JO - Advanced Materials Research

JF - Advanced Materials Research

SN - 1022-6680

ER -